Gastric bypass maintains weight loss and diabetes remission over 15 years, study shows

FHS
June 12, 2024
8:46 pm

Roux-en-Y gastric bypass, a type of weight-loss surgery, kept type 2 diabetes in remission for up to 15 years and most of the weight off for up to 20 years in one of the largest long-term studies of patients undergoing the procedure.

New study expands immunotherapy eligibility for colorectal and endometrial cancer patients

A new study shows thousands more patients diagnosed with colorectal and endometrial cancers could benefit from immunotherapy than are currently offered it.

December 29, 2023

Semaglutide May Help Smokers Quit, Study Suggests

Among patients with type 2 diabetes and tobacco use disorder (TUD), use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) was associated with a reduced

July 31, 2024

Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe – Biotech Investments

EQS-News: Marinomed Biotech AG / Key word(s): Contract Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe 26.03.2024 / 07:45

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.